CANNARA BIOTECH INC (LOVE.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:LOVE - CA13765U2002 - Common Stock
LOVE.CA Key Statistics, Chart & Performance
The current stock price of LOVE.CA is 1.69 CAD. In the past month the price increased by 3.68%. In the past year, price increased by 125.33%.
LOVE.CA Latest News, Press Relases and Analysis
LOVE.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| JWEL.CA | JAMIESON WELLNESS INC | 19.45 | 1.42B | ||
| GENX.CA | GENIX PHARMACEUTICALS CORP | N/A | 1.53M |
Related stock screener links
About LOVE.CA
Company Profile
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
Company Info
CANNARA BIOTECH INC
Suite 2050 - 1055, West Georgia Street
Vancouver BRITISH COLUMBIA V6E 3P3 CA
Employees: 13
Phone: 15149139136.0
CANNARA BIOTECH INC / LOVE.CA FAQ
What does LOVE do?
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
What is the current price of LOVE stock?
The current stock price of LOVE.CA is 1.69 CAD. The price increased by 1.2% in the last trading session.
Does LOVE stock pay dividends?
LOVE.CA does not pay a dividend.
What is the ChartMill rating of CANNARA BIOTECH INC stock?
LOVE.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists LOVE stock?
LOVE.CA stock is listed on the TSX Venture Exchange exchange.
What is the analyst forecast for LOVE.CA stock?
5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 111.24% is expected in the next year compared to the current price of 1.69.
When does CANNARA BIOTECH INC (LOVE.CA) report earnings?
CANNARA BIOTECH INC (LOVE.CA) will report earnings on 2026-01-26.
LOVE.CA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to LOVE.CA. When comparing the yearly performance of all stocks, LOVE.CA is one of the better performing stocks in the market, outperforming 85.48% of all stocks.
LOVE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA. LOVE.CA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
LOVE.CA Financial Highlights
Over the last trailing twelve months LOVE.CA reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 102.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.18% | ||
| ROA | 7.75% | ||
| ROE | 12.79% | ||
| Debt/Equity | 0.34 |
LOVE.CA Forecast & Estimates
5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 111.24% is expected in the next year compared to the current price of 1.69.
For the next year, analysts expect an EPS growth of 60% and a revenue growth 16.54% for LOVE.CA